Search

everythinglearnresearchcommunity

for

Search:↓

SJS/TEN survivors often have severe, overlooked long-term physical problems that are not properly treated after leaving the hospital.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

Eating disorders can cause skin problems that need treating the underlying condition for better health.

Finasteride reduces hair growth and is safe for women with excessive hair.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Finasteride and minoxidil together work best for male hair loss.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Severe insulin resistance can be managed with medication, lifestyle changes, and treatment for related conditions.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

SVF-enhanced adipose transplantation shows potential as a hair loss treatment.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Bariatric surgery affects skin health, causing both direct complications and changes in existing skin conditions, often related to nutritional deficiencies.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

Adult stem cells are important for tissue repair and have therapeutic potential, but more research is needed to fully use them.

The study found that mouse sweat glands develop before birth, mature after birth, and have specific keratin patterns.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

The VEGF +405G allele may increase the risk of PCOS in South Indian women.

Genetic marker rs12558842 strongly linked to male hair loss.

Thymosin β4 helps improve skin healing and reduce scarring.